Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.290
+0.110 (9.32%)
Nov 4, 2024, 4:00 PM EST - Market closed
Spero Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 4, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 70 | 78 | 90 | 518 | 527 | 184 | |
Market Cap Growth | -7.93% | -13.02% | -82.69% | -1.83% | 186.63% | 73.81% | |
Enterprise Value | 11 | -10 | 46 | 401 | 408 | 95 | |
Last Close Price | 1.29 | 1.47 | 1.73 | 16.01 | 19.39 | 9.62 | |
PE Ratio | 3.96 | 3.42 | -1.40 | -5.51 | -5.51 | -2.87 | |
PS Ratio | 0.58 | 0.75 | 1.67 | 28.35 | 56.50 | 10.13 | |
PB Ratio | 0.87 | 0.73 | 1.18 | 5.86 | 3.99 | 2.47 | |
P/FCF Ratio | -4.88 | -2.36 | -11.59 | -8.04 | -6.13 | -3.65 | |
P/OCF Ratio | -4.88 | -2.36 | -11.59 | -8.04 | -6.14 | -3.68 | |
EV/Sales Ratio | 0.09 | -0.10 | 0.86 | 21.98 | 43.72 | 5.24 | |
EV/EBITDA Ratio | 0.53 | -0.37 | -1.55 | -4.60 | -5.21 | -1.52 | |
EV/EBIT Ratio | 0.53 | -0.38 | -1.51 | -4.56 | -5.16 | -1.50 | |
EV/FCF Ratio | 0.48 | 0.31 | -5.95 | -6.24 | -4.74 | -1.89 | |
Debt / Equity Ratio | 0.06 | 0.05 | 0.09 | 0.63 | 0.06 | 0.07 | |
Debt / EBITDA Ratio | 0.22 | 0.19 | - | - | - | - | |
Debt / FCF Ratio | -0.34 | -0.17 | -0.86 | -0.87 | -0.09 | -0.11 | |
Asset Turnover | 0.95 | 0.68 | 0.36 | 0.11 | 0.07 | 0.15 | |
Quick Ratio | 2.61 | 3.42 | 5.09 | 7.98 | 9.28 | 3.40 | |
Current Ratio | 2.68 | 3.53 | 5.25 | 8.46 | 9.70 | 3.58 | |
Return on Equity (ROE) | 25.81% | 24.95% | -56.53% | -81.47% | -75.77% | -63.99% | |
Return on Assets (ROA) | 10.48% | 10.90% | -12.91% | -33.88% | -38.10% | -33.61% | |
Return on Capital (ROIC) | 17.82% | 17.17% | -16.86% | -38.73% | -44.95% | -40.32% | |
Earnings Yield | 25.03% | 29.27% | -51.82% | -17.34% | -14.85% | -33.13% | |
FCF Yield | -20.63% | -42.35% | -8.63% | -12.43% | -16.32% | -27.37% | |
Buyback Yield / Dilution | -12.90% | -40.98% | -21.65% | -38.01% | -23.27% | -13.49% | |
Total Shareholder Return | -12.90% | -40.98% | -21.65% | -38.01% | -23.27% | -13.49% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.